Page last updated: 2024-08-21

hydrazine and Heart Diseases

hydrazine has been researched along with Heart Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (60.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albitar, MX; Cahill, AL; Deangelo, DJ; Giles, FJ; Karsten, V; Kell, J; O'Brien, SM; Pigneux, A; Schiller, GJ; Solomon, S; Stuart, RK; Vey, N	1
Horton, JW; Maass, D; Sanders, B; White, J	1
Czarnecki, CM	1
Schwartz, A; Stanton, HC	1
Sundermann, A	1

Trials

1 trial(s) available for hydrazine and Heart Diseases

Article	Year
Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-10, Volume: 28, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Comorbidity; Europe; Female; Gene Expression Regulation, Leukemic; Heart Diseases; Humans; Hydrazines; Infusions, Intravenous; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid, Acute; Liver Diseases; Lung Diseases; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Treatment Outcome; United States	2010

Article

Year

Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-10, Volume: 28, Issue:5

Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Comorbidity; Europe; Female; Gene Expression Regulation, Leukemic; Heart Diseases; Humans; Hydrazines; Infusions, Intravenous; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid, Acute; Liver Diseases; Lung Diseases; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Treatment Outcome; United States

2010

Other Studies

4 other study(ies) available for hydrazine and Heart Diseases

Article	Year
Nitric oxide modulation of TNF-alpha-induced cardiac contractile dysfunction is concentration dependent. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:6 Topics: Animals; Azetidines; Dose-Response Relationship, Drug; Heart Diseases; Hydrazines; In Vitro Techniques; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Donors; Osmolar Concentration; Penicillamine; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Tumor Necrosis Factor-alpha	2000
Toxicity of 1,2-diethylhydrazine fed to turkey poults. Research communications in chemical pathology and pharmacology, 1989, Volume: 63, Issue:2 Topics: Administration, Oral; Animals; Body Weight; Eating; Electrocardiography; Heart Diseases; Hydrazines; Intubation, Gastrointestinal; Male; Poultry Diseases; Turkeys	1989
Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats. Proceedings of the Western Pharmacology Society, 1966, Volume: 9 Topics: Animals; Blood Pressure; Body Weight; DNA; Female; Heart Diseases; Heart Rate; Hydrazines; Iproniazid; Isocarboxazid; Isoproterenol; Mitochondria; Monoamine Oxidase Inhibitors; Nialamide; Organ Size; Pargyline; Phenelzine; Potassium; Rats; RNA; Sodium; Tranylcypromine	1966
[Current treatment of cardiovascular diseases with special reference to long-term therapy]. Zeitschrift fur arztliche Fortbildung, 1967, Jun-15, Volume: 61, Issue:12 Topics: Angina Pectoris; Anti-Bacterial Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Diet Therapy; Digitalis Glycosides; Heart Diseases; Heart Failure; Humans; Hydrazines; Hypertension; Long-Term Care; Methyldopa; Phytotherapy; Plants, Medicinal; Rauwolfia; Rheumatic Fever; Sympatholytics; Sympathomimetics	1967